📰 Jack Weinstein News
Page 35 - Jack Weinstein News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jack Weinstein. Real-time updates on events, politics, business and more.
October 13, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous/Miscellaneous Relief Reports that its U.S. Collaboration Partner has Announced Progress on Worldwide Commercial Scale Development of ZYESAMI(TM) (aviptadil) 13-Oct-2021 / 07:00 CET/CEST Release of an ad hoc announcemen...
October 11, 2021
The 1850 Civil War occurred when states’ rights and federal authority collided; another civil war is possible
October 11, 2021
The 1850 Civil War occurred when states’ rights and federal authority collided; another civil war is possible
October 11, 2021
The 1850 Civil War occurred when states’ rights and federal authority collided; another civil war is possible
October 7, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Legal Matter Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan Javitt, for RLF-100(TM) (Aviptadil) 07-Oct-2021 / 01:30 CET/CEST Release of an ad hoc annou...
October 7, 2021
Acer Forward-Looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private... | October 7, 2021
October 7, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00
October 7, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Legal Matter Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr. Jonathan
October 7, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word: Legal Matter Relief Therapeutics Announces Filing of Lawsuit Against its U.S. Collaboration Partner, NeuroRx, Inc. and its CEO, Dr.... | October 7, 2021
October 7, 2021
EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsibl...